pantoprazole has been researched along with Cirrhosis in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assalin, HB | 3 |
| De Almeida, KCG | 3 |
| Guadagnini, D | 3 |
| Santos, A | 3 |
| Teixeira, CJ | 3 |
| Bordin, S | 3 |
| Rocha, GZ | 3 |
| Saad, MJA | 3 |
1 other study available for pantoprazole and Cirrhosis
| Article | Year |
|---|---|
Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver.
Topics: Animals; Fibrosis; Gastrointestinal Microbiome; Humans; Lipopolysaccharides; Mice; Mice, Inbred C57B | 2022 |
Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver.
Topics: Animals; Fibrosis; Gastrointestinal Microbiome; Humans; Lipopolysaccharides; Mice; Mice, Inbred C57B | 2022 |
Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver.
Topics: Animals; Fibrosis; Gastrointestinal Microbiome; Humans; Lipopolysaccharides; Mice; Mice, Inbred C57B | 2022 |
Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver.
Topics: Animals; Fibrosis; Gastrointestinal Microbiome; Humans; Lipopolysaccharides; Mice; Mice, Inbred C57B | 2022 |
Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver.
Topics: Animals; Fibrosis; Gastrointestinal Microbiome; Humans; Lipopolysaccharides; Mice; Mice, Inbred C57B | 2022 |
Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver.
Topics: Animals; Fibrosis; Gastrointestinal Microbiome; Humans; Lipopolysaccharides; Mice; Mice, Inbred C57B | 2022 |
Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver.
Topics: Animals; Fibrosis; Gastrointestinal Microbiome; Humans; Lipopolysaccharides; Mice; Mice, Inbred C57B | 2022 |
Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver.
Topics: Animals; Fibrosis; Gastrointestinal Microbiome; Humans; Lipopolysaccharides; Mice; Mice, Inbred C57B | 2022 |
Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver.
Topics: Animals; Fibrosis; Gastrointestinal Microbiome; Humans; Lipopolysaccharides; Mice; Mice, Inbred C57B | 2022 |